Merit Financial Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.4K Buy
+16,211
New +$39.6K ﹤0.01% 2307
2025
Q2
Sell
-10,325
Closed -$44.6K 1737
2025
Q1
$44.6K Buy
+10,325
New +$41.7K ﹤0.01% 1376

Other funds holding ORGO

Merit Financial Group's ORGO Position: Q2 2026 in Review

Merit Financial Group opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 16,211 shares worth $39.4K. The stake represents ﹤0.01% of the portfolio and ranks #2307 among its holdings. This is a return to the name: Merit Financial Group previously reported a position in ORGO as recently as Q1 2025.

Merit Financial Group first reported a position in ORGO in Q1 2025 and has held it in 2 quarters since. The position peaked at $44.6K in Q1 2025. 10 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Merit Financial Group held 16,211 shares of Organogenesis Holdings worth $39.4K as of Q2 2026.
  • Organogenesis Holdings was a new Merit Financial Group position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2307 holding.
  • Merit Financial Group first reported a position in Organogenesis Holdings in Q1 2025 and has held it in 2 quarters since.
  • Merit Financial Group's Organogenesis Holdings position peaked at $44.6K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.